β-CCB is a ligand for benzodiazepine receptor, which inhibits the binding of [ 3 H]flunitrazepam and ethyl (3-[ 3 H]carboline-3-carboxylate to benzodiazepine receptors, with K i of 3-4 nM. β-CCB exhibits proconvulsant and anxiogenic effects.
Products | Products > Disease Areas > Neurological, Eye or Ear Disease | Products > Signaling Pathways > Membrane Transporter/Ion Channel | Products > Signaling Pathways > Neuronal Signaling | Products > Research Areas > Neurological Disease | Products > Signaling Pathways > GABA Receptor
Please leave a message for us or use the following ways to contact us, we will reply to you as soon as possible, and provide you with the most sincere service, thank you.